Возможности применения лекарственных средств с иммуномодулирующей активностью (ксимедона и димефосфона) при хронической ревматической болезни сердца

In the study of dynamics indicators of immunity at 290 patients chronic rheumatic heart disease it was shown that complex treatment with inclusion of medicines with immunomodulatory activity xymedon and dimephosphon unlike traditional therapy increased quantity CD3+-, CD4+and CD8+-Т-лимфоцитов, restored to normal values suppressive activity of lymphocytes, stimulated the functional activity of lymphocytes, leads to rapid normalization indicators of bactericidal and cytotoxic activity and levels of serum immunoglobulins.. During regenerative treatment patients the chronic rheumatic heart disease to apply methods immunocorrection recommends, including original domestic preparations xymedon and dimephosphon.